npj Parkinsons Disease is a leading open-access journal dedicated to advancing research in the field of Parkinson's disease and related neurodegenerative disorders. Published by NATURE PORTFOLIO, this journal has been on the forefront of scientific inquiry since its inception in 2015, providing a high-quality platform for the dissemination of groundbreaking research. The journal's reputation is underscored by its impressive Q1 rankings in Cellular and Molecular Neuroscience and Neurology categories, as well as its commendable positions in Scopus rankings, placing it within the top echelons of neuroscience and clinical neurology research. With its focus on innovative methodologies and translational studies, npj Parkinsons Disease aims to foster collaboration among researchers, clinicians, and healthcare professionals, ultimately contributing to the improved understanding and treatment of Parkinson's disease. Researchers, professionals, and students are encouraged to explore its rich repository of knowledge, accessible freely since its launch, to stay abreast of the latest developments in this critical area of neuroscience.

FREE RADICAL BIOLOGY AND MEDICINE, published by Elsevier Science Inc, is a premier journal dedicated to the field of biochemistry and medical physiology. With an ISSN of 0891-5849 and an E-ISSN of 1873-4596, this journal stands out with its impressive ranking in the 2023 category quartiles: Q1 in Biochemistry and Q1 in Physiology (medical). Specifically, it has achieved a remarkable position of 29th out of 438 in Biochemistry and 8th out of 113 in Physiology, placing it firmly in the 93rd percentile of its field, as per Scopus rankings. Since its inception in 1987, the journal has focused on advancing the understanding of free radicals and their role in biological processes, encompassing a wide range of topics from oxidative stress to therapeutic applications. Although it does not currently offer open access, the journal's rigorous peer-review process and impactful research ensure that it remains a valuable resource for researchers and professionals seeking to explore the intricate relationships between free radicals and health. The journal's headquarters are located at STE 800, 230 Park Ave, New York, NY 10169, reflecting its esteemed place within the scientific community and commitment to high-quality research.

Mitochondrial DNA Part B-Resources, published by TAYLOR & FRANCIS LTD, is a prominent academic journal focusing on the vast and evolving field of genetics and molecular biology. As an open access resource, it is dedicated to providing valuable insights and comprehensive data on mitochondrial DNA, an area crucial for understanding cellular functions, genetic inheritance, and various diseases. Although relatively new, having commenced in 2016, the journal has gained recognition with its current Scopus rankings placing it in the lower quartiles for both Genetics and Molecular Biology. It serves as an essential platform for researchers, professionals, and students at the intersection of genetics and biotechnology, fostering collaboration and innovation. With a commitment to quality research and accessibility, Mitochondrial DNA Part B-Resources is poised to contribute significantly to the scientific community until at least 2024 and beyond.

TRENDS IN ENDOCRINOLOGY AND METABOLISM, published by CELL PRESS, stands as a pivotal resource in the fields of endocrinology, diabetes, and metabolism. With its ISSN 1043-2760 and E-ISSN 1879-3061, this esteemed journal has been a leading platform since its inception in 1989, currently projected to span until 2024. Recognized within the top quartile (Q1) of its category, it boasts impressive Scopus rankings, holding the 4th position in Endocrinology and 8th in Endocrinology, Diabetes, and Metabolism. These rankings underscore its significant impact, evidenced by an impressive percentile rank of 97th and 96th respectively. The journal is committed to facilitating the dissemination of cutting-edge research and innovative insights, making it an essential read for researchers, clinicians, and students seeking to stay informed on the latest advancements in these critical fields. With a robust focus on providing thorough reviews and original research articles, TRENDS IN ENDOCRINOLOGY AND METABOLISM continues to shape the understanding and treatment of metabolic disorders.

AGING CELL is a premier peer-reviewed journal published by Wiley, specializing in the rapidly evolving field of aging research and cell biology. Established in 2002 and enjoying an impressive track record as evidenced by its Q1 ranking in both Aging and Cell Biology categories for 2023, the journal has become a vital resource for researchers and professionals alike. With a significant impact factor highlighting its scholarly influence, AGING CELL offers an open access model since 2014, ensuring that groundbreaking research is accessible to the global community. The journal covers a wide array of topics related to the mechanisms of aging at the cellular and molecular levels, making it essential reading for anyone invested in understanding the complexities of aging processes and their implications for health and disease. With a broad international readership based in the United Kingdom and beyond, AGING CELL is dedicated to disseminating high-quality research that impacts scientific understanding and fosters advances in the field.

npj Aging and Mechanisms of Disease is a leading open-access journal dedicated to advancing the understanding of the biological mechanisms underlying aging and age-related diseases. Published by NATURE PORTFOLIO in the United Kingdom, this journal has established itself as a vital resource within the fields of Aging and Geriatrics and Gerontology, proudly holding a prestigious Q1 ranking in both categories as of 2023. With an impressive Scopus ranking, placing it in the top 10 for Geriatrics and Gerontology, and the top 9 for Aging, the journal is committed to disseminating high-quality, peer-reviewed research that offers innovative insights and fosters collaboration among researchers and practitioners. Since its inception in 2015, npj Aging and Mechanisms of Disease has embraced the open-access model, ensuring that groundbreaking findings are freely available to all, thereby promoting widespread knowledge-sharing within the scientific community. This journal serves as an essential platform for those seeking to explore the complex interplay of genetic, molecular, and environmental factors that influence aging and its associated challenges.

Nature Metabolism, published by NATURE PORTFOLIO, is a leading journal dedicated to advancing the field of metabolic research and its implications across various biological systems. Since its inception in 2019, this esteemed journal has rapidly established itself as a vital resource for researchers, professionals, and students alike, reflecting its prominence through a prestigious Q1 ranking in several key categories including Cell Biology, Endocrinology, Diabetes and Metabolism, Internal Medicine, and Physiology. With an impressive Scopus ranking, underscoring its impact in Medicine and Biochemistry disciplines, Nature Metabolism offers an exceptional platform for disseminating high-quality research that explores the intricate mechanisms of metabolism and its association with health and disease. Although currently not open access, it continues to gain visibility and appreciation within the scientific community, ensuring that groundbreaking findings reach interested audiences globally from its hub in Berlin, Germany. Whether you are an experienced researcher or an aspiring student, Nature Metabolism serves as an invaluable asset in navigating the complexities of metabolic science.

REDOX REPORT is a peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the latest advancements in the fields of biochemistry, clinical biochemistry, and physiology. Since its inception in 1996 and transitioning to an Open Access model in 2018, this journal has aimed to disseminate high-quality research findings and foster discussions within the scientific community. Positioned in the Q2 quartile across several relevant categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, REDOX REPORT is recognized for its commitment to impactful research. The journal plays a crucial role in bridging the gap between fundamental biochemical research and its clinical applications, making it an essential resource for researchers, professionals, and students alike. With a consistent publication record extending to 2024, REDOX REPORT is dedicated to featuring cutting-edge studies that advance our understanding of redox biology, thereby contributing significantly to the ongoing dialogue in the life sciences.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS is a prestigious journal published by Elsevier, dedicated to advancing the fields of biochemistry, biophysics, and cell biology. Established in 1967, this journal is committed to disseminating high-quality research that unveils the molecular mechanisms of bioenergetics, encompassing a wide range of topics from mitochondrial function to energy metabolism. With an exceptional impact factor and a current ranking in the Q1 quartile across multiple categories—specifically ranked #13 in Biophysics and featuring strong positions in Biochemistry and Cell Biology—this journal is recognized for its influential contributions to the scientific community. Scholars, researchers, and students globally benefit from its rigorous peer-review process and access options, although it is not currently open access. By providing a platform for innovative research, BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS plays a critical role in fostering scientific advancement and collaboration among professionals in the field.

RUSSIAN JOURNAL OF GENETICS is a significant platform in the field of genetics, published by PLEIADES PUBLISHING INC since its inception in 1996. With an ISSN of 1022-7954 and an E-ISSN of 1608-3369, the journal focuses on a wide array of topics within genetics, providing researchers, professionals, and students with insights into advancements and discoveries in this ever-evolving discipline. While it currently holds a Q4 ranking in the 2023 Genetics category according to Scopus, representing invaluable opportunities for knowledge dissemination, the journal is actively working to enhance its impact in future rankings. Readers will find the journal a repository of diverse genetic research findings, methodologies, and theoretical advancements. Although it is not an open-access journal, it is committed to serving the academic community through rigorous peer-reviewed articles. With a consistent publication trajectory spanning to 2024, the RUSSIAN JOURNAL OF GENETICS remains a crucial resource for those aspiring to stay at the forefront of genetic research and applications.